Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series-Reference-Cited by-同舟云学术

Antibody Response to a Fourth Messenger RNA COVID-19 Vaccine Dose in Kidney Transplant Recipients: A Case Series

Published:2022-03 Issue:3 Volume:175 Page:455-456
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Caillard Sophie¹^ORCID,Thaunat Olivier²^ORCID,Benotmane Ilies¹,Masset Christophe³,Blancho Gilles³^ORCID

Affiliation:

1. Department of Nephrology and Transplantation, University Hospitals of Strasbourg, INSERM Unit 1109, Strasbourg, France

2. Department of Transplantation Nephrology and Clinical Immunology, Hospices Civils de Lyon, Claude Bernard Lyon 1 University, INSERM Unit 1111, Lyon, France

3. Institut de Transplantation Urologie Néphrologie, Centre Hospitalier Universitaire de Nantes, Centre de Recherche en Transplantation et Immunologie, UMR 1064, INSERM, Nantes Université, Nantes, France

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Reference5 articles.

1. Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients

2. Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses

3. Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients

4. Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

5. Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Predictive Factors Associated with Poor Response after Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Lung Transplant Patients;Vaccines;2024-07-22

2. Dietary Inulin to Improve SARS-CoV-2 Vaccine Response in Kidney Transplant Recipients: The RIVASTIM-Inulin Randomised Controlled Trial;Vaccines;2024-06-03

3. Additional SARS-CoV-2 vaccine doses: a little is better than none;The Lancet Rheumatology;2024-06

4. Challenges Faced by Solid Organ Transplant Recipients During the COVID-19 Pandemic in France: Historical Insights and Key Takeaways;Transplantation;2024-03-23

5. Psoriasis and biological drugs at the time of SARS-CoV-2 infection: a mini review outlining risk of infection, seroprevalence, and safety and efficacy of the BNT162b2 vaccine;Frontiers in Immunology;2024-01-30